Copyright
©The Author(s) 2024.
World J Diabetes. Jun 15, 2024; 15(6): 1074-1078
Published online Jun 15, 2024. doi: 10.4239/wjd.v15.i6.1074
Published online Jun 15, 2024. doi: 10.4239/wjd.v15.i6.1074
Ref. | Country | Sample size | Heart disease | Level of γ-GGT | Level of bilirubin | Citation journal | Year |
Ruttmann et al[4] | Austria | 163944 | Various CVDs | Significantly associated with CVD mortality | - | Circulation | 2005 |
Emiroglu et al[2] | Turkey | ACS: 219; Control: 51 | Acute coronary syndrome | Higher in ACS patients | - | Acta Diabetol | 2010 |
Fukui et al[8] | - | 633 | T2DM | - | Inversely correlated with albuminuria and subclinical atherosclerosis | Kidney Int | 2008 |
Dalos et al[3] | - | HFpEF: 274 | Heart failure with preserved ejection fraction | Independently associated with outcome | - | Sci Rep | 2019 |
Passamonti et al[10] | - | - | - | - | Present in endothelial cells, antioxidative capacity | Meta Gene | 2018 |
Lin et al[9] | - | - | - | - | Inversely associated with CVD and related diseases | Clinical Chemistry | 2010 |
Cho et al[5] | Korea | 9687066 | General CVD | Increased levels associated with all-cause and CVD mortality | - | Sci Rep | 2023 |
Baek et al[6] | Korea | 1640127 | Myocardial infarction, stroke, CVD | Cumulative high levels associated with increased CVD risk | - | Endocrinol Metab (Seoul) | 2023 |
Chen et al[1] | China | T2DM + ACS: 96; T2DM: 85; ACS: 90 | ACS | Increased in T2DM + ACS | Protective factor | World J Diabetes | 2023 |
- Citation: Al-Suhaimi EA, Al-Rubaish AA. Interplay of serum biomarkers bilirubin and γ-glutamyltranspeptidase in predicting cardiovascular complications in type-2 diabetes mellitus. World J Diabetes 2024; 15(6): 1074-1078
- URL: https://www.wjgnet.com/1948-9358/full/v15/i6/1074.htm
- DOI: https://dx.doi.org/10.4239/wjd.v15.i6.1074